What is the typical treatment for acute exacerbation of asthma in adults?

The typical treatment for acute exacerbation of asthma in adults is a short-acting beta agonist (SABA). SABAs, such as albuterol, are fast-acting bronchodilators that work by relaxing the smooth muscles in the airways, leading to rapid relief of bronchoconstriction. They are the first-line therapy for acute asthma symptoms and are used as rescue medications because they can quickly open up the airways and improve airflow.

During an acute exacerbation, patients often experience wheezing, shortness of breath, and chest tightness. The immediate goal of treating an exacerbation is to relieve these symptoms, and SABAs can provide relief within minutes. This quick response makes them an essential component of acute asthma management.

Long-acting beta agonists, while effective in asthma management, are not appropriate for acute exacerbations due to their slower onset of action. Inhaled corticosteroids are important for long-term control and reducing inflammation but take longer to exert their effects and are not suitable for immediate relief during an acute episode. Leukotriene receptor antagonists are also more beneficial for chronic asthma management rather than for the quick relief needed during an exacerbation. Therefore, short-acting beta agonists are the preferred choice for treating